Lotus Eye Hospital: Decides Against Voluntary Delisting From NSE

Hexaware Technologies: Launches AgentVers Platform Featuring Over 600 Available Enterprise AI Agents

PNGS REVA DIAMOND JEWELLER: Q3 REVENUE 1.44B RUPEES VS 1.03B (YOY)

PNGS REVA DIAMOND JEWELLER: Q3 EBITDA 336M RUPEES VS 193M (YOY) || Q3 EBITDA MARGIN 23.3% VS 18.74% (YOY)

PNGS REVA DIAMOND JEWELLER: Q3 SL NET PROFIT 231M RUPEES VS 126M (QOQ)

AYE FINANCE: Q3 SL NET PROFIT 430M RUPEES VS 240M (YOY)

AYE FINANCE: Q3 REVENUE 4.4B RUPEES VS 3.6B (YOY)

FRACTAL ANALYTICS: Q3 EBITDA 1.3B RUPEES VS 884M (YOY) || Q3 EBITDA MARGIN 15.04% VS 12.50% (YOY)

FRACTAL ANALYTICS: Q3 CONS NET PROFIT 1.02B RUPEES VS 928M (YOY) || Q3 REVENUE 8.5B RUPEES VS 7B (YOY)

RAIN INDUSTRIES: Q3 EBITDA 501M RUPEES VS 346M (YOY) || Q3 EBITDA MARGIN 11.65% VS 9.41% (YOY)

RAIN INDUSTRIES: Q3 CONS NET PROFIT 135M RUPEES VS LOSS 1.6B (YOY) || Q3 REVENUE 43B RUPEES VS 36.8B (YOY)

VESUVIUS INDIA: Q3 EBITDA 936M RUPEES VS 819M (YOY) || Q3 EBITDA MARGIN 16.99% VS 16.11% (YOY)

VESUVIUS INDIA: Q3 SL NET PROFIT 802M RUPEES VS 599M (YOY) || Q3 REVENUE 5.5B RUPEES VS 5.1B (YOY)

FOSECO INDIA: CO HAS EXCEPTIONAL ITEM OF 169M RUPEES || Q3 PBT 404M RUPEES VS 263M (YOY)

FOSECO INDIA: Q3 EBITDA 419M RUPEES VS 229M (YOY) || Q3 EBITDA MARGIN 22.44% VS 16.78% (YOY)

FOSECO INDIA: Q3 CONS NET PROFIT 126M RUPEES VS 195M (YOY) || Q3 REVENUE 1.87B RUPEES VS 1.4B (YOY)

SANOFI CONSUMER HEALTHCARE: Q3 EBITDA 898M RUPEES VS 621M (YOY) || Q3 EBITDA MARGIN 35.78% VS 36.38% (YOY)